Published in Antimicrob Agents Chemother on February 01, 1982
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax (2001) 4.68
Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects. Antimicrob Agents Chemother (1983) 1.92
Ampicillin versus cefamandole as initial therapy for community-acquired pneumonia. Antimicrob Agents Chemother (1987) 1.08
Cefonicid concentrations in serum and atrial tissue during open-heart surgery. Antimicrob Agents Chemother (1983) 0.85
Clinical trial of cefonicid for treatment of skin infections. Antimicrob Agents Chemother (1983) 0.75
Azlocillin and cefonicid penetration into bone enhanced by probenecid. Antimicrob Agents Chemother (1984) 0.75
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Antimicrob Agents Chemother (1981) 2.04
Penetration of antimicrobial agents into bronchial secretions. Am J Med (1975) 1.74
Practical considerations in using counterimmunoelectrophoresis to identify the principal causative agents of bacterial meningitis. J Clin Microbiol (1979) 1.47
The role of cefamandole in the treatment of Haemophilus influenzae infections in infants and children. J Pediatr (1981) 1.25
Clinical and laboratory evaluation of cefamandole in the therapy of Haemophilus spp. Bronchopulmonary infections. Antimicrob Agents Chemother (1979) 1.00
Double-blind comparison of cefamandole and penicillin in pneumococcal pneumonia. Antimicrob Agents Chemother (1978) 0.99
Development of Haemophilus influenzae meningitis in patients treated with cefamandole. J Pediatr (1981) 0.92
Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med (1994) 12.68
Chromosomal DNA fingerprint patterns produced with IS6110 as strain-specific markers for epidemiologic study of tuberculosis. J Clin Microbiol (1991) 8.24
Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis (1983) 5.66
PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J Clin Microbiol (1995) 4.27
Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother (1985) 4.09
Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis (1993) 3.86
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother (1992) 3.69
Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA (2000) 3.50
Haemophilus influenzae infections in adults: characterization of strains by serotypes, biotypes, and beta-lactamase production. J Infect Dis (1981) 3.45
Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States. Ann Intern Med (1998) 3.41
Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother (1994) 3.28
Nontypable Haemophilus influenzae (biotype 4) as a neonatal, maternal, and genital pathogen. Rev Infect Dis (1983) 3.23
Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1999) 3.16
Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis (1985) 3.16
Rapid identification of clinically significant species and taxa of aerobic actinomycetes, including Actinomadura, Gordona, Nocardia, Rhodococcus, Streptomyces, and Tsukamurella isolates, by DNA amplification and restriction endonuclease analysis. J Clin Microbiol (1997) 3.12
DNA polymorphisms in strains of Mycobacterium tuberculosis analyzed by pulsed-field gel electrophoresis: a tool for epidemiology. J Clin Microbiol (1992) 2.89
Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J Clin Microbiol (1986) 2.87
Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol (2001) 2.81
Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis (1997) 2.78
Disk diffusion susceptibility testing of Nocardia species. J Infect Dis (1977) 2.77
Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents. Antimicrob Agents Chemother (1979) 2.74
Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov. Int J Syst Bacteriol (1995) 2.50
Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy. Int J Syst Evol Microbiol (2001) 2.38
A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. J Infect Dis (1998) 2.34
The EuroPhysiome, STEP and a roadmap for the virtual physiological human. Philos Trans A Math Phys Eng Sci (2008) 2.32
Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic tool. J Clin Microbiol (1993) 2.25
Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis (1982) 2.22
Histamine dose-response curves in asthma: reproducibility and sensitivity of different indices to assess response. Thorax (1983) 2.22
DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex. J Clin Microbiol (1995) 2.16
Amoxicillin-clavulanic acid in the treatment of lower respiratory tract infections caused by beta-lactamase-positive Haemophilus influenzae and Branhamella catarrhalis. Antimicrob Agents Chemother (1985) 2.08
Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci (2003) 2.07
Large restriction fragment patterns of genomic Mycobacterium fortuitum DNA as strain-specific markers and their use in epidemiologic investigation of four nosocomial outbreaks. J Clin Microbiol (1992) 2.07
Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis (1982) 2.06
Microbial ecology and activities in the rumen: part 1. Crit Rev Microbiol (1982) 2.06
Microbial ecology and activities in the rumen: Part II. Crit Rev Microbiol (1982) 1.98
Pyogenic granuloma (lobular capillary hemangioma): a clinicopathologic study of 178 cases. Pediatr Dermatol (1991) 1.96
Clinical application of PCR-restriction enzyme pattern analysis for rapid identification of aerobic actinomycete isolates. J Clin Microbiol (1998) 1.93
Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch Intern Med (1986) 1.92
Isoelectric focusing patterns of beta-lactamases in the rapidly growing mycobacteria. Tuber Lung Dis (1992) 1.89
Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung disease. Clin Infect Dis (1995) 1.78
Recognition of a Nocardia transvalensis complex by resistance to aminoglycosides, including amikacin, and PCR-restriction fragment length polymorphism analysis. J Clin Microbiol (1997) 1.77
Mycobacterium chelonae causing otitis media in an ear-nose-and-throat practice. N Engl J Med (1988) 1.75
Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med (1983) 1.75
Nocardia pseudobrasiliensis sp. nov., a new species of Nocardia which groups bacterial strains previously identified as Nocardia brasiliensis and associated with invasive diseases. Int J Syst Bacteriol (1996) 1.74
Maintenance of viability and comparison of identification methods for influenza and other respiratory viruses of humans. J Clin Microbiol (1977) 1.73
5' dinucleotide repeat polymorphism of NRAMP1 and susceptibility to tuberculosis among Caucasian patients in Houston, Texas. Int J Tuberc Lung Dis (2002) 1.71
Development of bactericidal antibody during Branhamella catarrhalis infection. J Infect Dis (1985) 1.71
Immunofluorescent diagnosis of acute viral infection. South Med J (1975) 1.71
Fatal poisoning from sodium phosphate enema. Case report and experimental study. JAMA (1987) 1.71
Bacterial spinal epidural abscess. Review of 43 cases and literature survey. Medicine (Baltimore) (1992) 1.71
Paternal and maternal depressed mood during the transition to parenthood. J Affect Disord (2000) 1.71
Abbreviated laparotomy and planned reoperation for critically injured patients. Ann Surg (1992) 1.70
Chronic tenosynovitis of the hand due to Mycobacterium nonchromogenicum: use of high-performance liquid chromatography for identification of isolates. Rev Infect Dis (1992) 1.70
Effects of tetracycline on leukotaxis. J Infect Dis (1974) 1.69
Hemophilus influenzae pneumonia in adults. Am J Med (1978) 1.69
Differences among Nocardia spp. in susceptibility to aminoglycosides and beta-lactam antibiotics and their potential use in taxonomy. Antimicrob Agents Chemother (1983) 1.67
Dual respiratory virus infections. Clin Infect Dis (1997) 1.67
Report on an outbreak of postinjection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction. Clin Infect Dis (1997) 1.67
Spectrum of clinical illness in hospitalized patients with "common cold" virus infections. Clin Infect Dis (2000) 1.66
In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria. Rev Infect Dis (1982) 1.66
Altered morphology and increased acid hydrolase content of pulmonary macrophages from cigarette smokers. Am Rev Respir Dis (1973) 1.65
Influenza: its control in persons and populations. J Infect Dis (1986) 1.65
Nosocomial outbreak of respiratory tract colonization with Mycobacterium fortuitum: demonstration of the usefulness of pulsed-field gel electrophoresis in an epidemiologic investigation. Am Rev Respir Dis (1991) 1.64
In vitro activities of linezolid against multiple Nocardia species. Antimicrob Agents Chemother (2001) 1.62
Opsonizing and bactericidal effects of normal human serum on nontypable Haemophilus influenzae. Infect Immun (1983) 1.62
Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. J Infect Dis (1996) 1.61
Influence of plant phenolic acids on growth and cellulolytic activity of rumen bacteria. Appl Environ Microbiol (1982) 1.59
Tetracycline resistance determinants in Mycobacterium and Streptomyces species. Antimicrob Agents Chemother (1994) 1.59
Urogenital, maternal and neonatal isolates of Haemophilus influenzae: identification of unusually virulent serologically non-typable clone families and evidence for a new Haemophilus species. J Gen Microbiol (1990) 1.59
Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex. Clin Pharmacol Ther (1991) 1.58
Management of the difficult duodenal stump. Am J Surg (1991) 1.57
Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med (2001) 1.55
Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med (1998) 1.55
Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine. J Infect Dis (1994) 1.55
Lack of rifabutin resistance with prophylaxis for disseminated Mycobacterium avium complex. Lancet (1994) 1.55
Beta-lactamase production and resistance to beta-lactam antibiotics in Nocardia. Antimicrob Agents Chemother (1978) 1.55
Resistance to cefamandole: a collaborative study of emerging clinical problems. J Infect Dis (1982) 1.54
Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects. Antimicrob Agents Chemother (1992) 1.53
Novel natural products from soil DNA libraries in a streptomycete host. Org Lett (2000) 1.52
Mycobacterium avium complex lung disease and women. Now an equal opportunity disease. Chest (1994) 1.52
Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis (1982) 1.52
Herpes zoster-associated encephalitis: clinicopathologic report of 12 cases and review of the literature. Medicine (Baltimore) (1983) 1.50
Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system. Antimicrob Agents Chemother (1992) 1.50
Right ventricular function and exercise performance late after primary repair of tetralogy of Fallot with the transannular patch in infancy. Am J Cardiol (1998) 1.49
Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid. Antimicrob Agents Chemother (1991) 1.48
Pneumatosis intestinalis in two infants with rotavirus gastroenteritis. Pediatr Radiol (1991) 1.47
Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. Clin Infect Dis (1995) 1.47
Randomly amplified polymorphic DNA PCR for comparison of Mycobacterium abscessus strains from nosocomial outbreaks. J Clin Microbiol (1997) 1.47
Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication. Emerg Infect Dis (1999) 1.47
Use of stable isotopes to measure de novo synthesis and turnover of amino acid-C and -N in mixed micro-organisms from the sheep rumen in vitro. Br J Nutr (2004) 1.46
Induction of aryl hydrocarbon hydroxylase in human pulmonary alveolar macrophages by cigarette smoking. J Clin Invest (1973) 1.45